EDGAR Filing Documents for 0001104659-13-091964

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

SEC Accession No. 0001104659-13-091964

Filing Date

2013-12-23

Accepted

2013-12-23 16:05:51

Documents

Period of Report

2013-10-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q/A	a13-24801_310qa.htm	10-Q/A	115891
	Complete submission text file	0001104659-13-091964.txt		3569266

Data Files

Seq	Description	Document	Type	Size
2	XBRL INSTANCE DOCUMENT	kpti-20130930.xml	EX-101.INS	502073
3	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	kpti-20130930.xsd	EX-101.SCH	30514
4	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	kpti-20130930_cal.xml	EX-101.CAL	33777
5	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	kpti-20130930_def.xml	EX-101.DEF	185452
6	XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT	kpti-20130930_lab.xml	EX-101.LAB	585610
7	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	kpti-20130930_pre.xml	EX-101.PRE	287050

Mailing Address 2 MERCER ROAD NATICK MA 01760

Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820

Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)